Patricia Carr, SVP, Chief Accounting Officer at Jazz Pharmaceuticals plc (JAZZ), sold 6,708 shares at $120.85 ($795K) on 2024-03-06, disclosed to the SEC on 2024-03-08.
Seasonal sale ($795k) by SVP, Chief Accounting Officer — this insider has traded JAZZ in March in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $117.51 | 700 | $82K | 10.4% |
| 2 | $120.85 | 1,236 | $149K | 18.8% |
| 3 | $120.85 | 1,236 | $149K | 18.8% |
| 4 | $116.98 | 1,768 | $207K | 26.0% |
| 5 | $116.98 | 1,768 | $207K | 26.0% |
| Total | $118.46 avg | 6,708 |
| $795K |
| 100% |
| Filing → |
| JAZZ | SELL | 2025-12-09 | $798K | — | Filing → |
| JAZZ | SELL | 2025-11-20 | $1.9M | — | Filing → |
| JAZZ | SELL | 2025-03-11 | $314K | — | Filing → |